DXCM DEXCOM INC
2026Q1 · CUSIP 252131107 · Sector: Healthcare & Biotech
Lit · Institutions accelerating in
Holders
954
Δ holders QoQ
+34
Breadth percentile
Top 8%
Whale holders
300
Δ whales
-5
Inst. holding value
$22.5B
New positions
148
Closed positions
114
Price momentum (1Q)
-7.6%
Put / Call
26/23
Breadth history (34 quarters)
Past Lit Events & Aftermath 15 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2026Q1 | Top 8% | — | — |
| 2024Q4 | Top 8% | -3.9% | -10.6% |
| 2024Q1 | Top 3% | -40.9% | -42.2% |
| 2023Q4 | Top 6% | +12.2% | -33.6% |
| 2023Q2 | Top 2% | -8.8% | +5.9% |
| 2022Q4 | Top 1% | +1.5% | -9.6% |
| 2021Q4 | Top 2% | -25.4% | -15.4% |
| 2021Q3 | Top 1% | -36.2% | -52.4% |
Options Sentiment
Put holders
26
QoQ: -3
Call holders
23
QoQ: -10
See methodology →
Fundamentals
PE (TTM)
32.5
EPS (TTM)
$2.33
EPS YoY
+75.2%
Revenue (TTM)
$4.8B
Revenue YoY
+16.2%
Net margin
19.3%
ROE
31.5%
Debt ratio
55.4%
FCF (TTM)
$1.4B
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.